Limaprost-d3 Catalog No.:M26610-C The blocking Bcr-Abl kinase activity

The blocking Bcr-Abl kinase activity using PD180970 in the human K562 CML cell line resulted in inhibition of Stat5 DNA-binding activity with an IC50 of 5 nM

COC1=CC=C(C=C1OC)C(=O)NCC1C=CC(=CC=1)OCCN(C)C

US20130121954A1

Such insulin sensitisation may be partly attributable to the effects of Rosiglitazone on the expression of molecules involved in the insulin signalling cascade

The binding of both OBE022 and OBE002 is reversible and competitive since increasing concentrations of either compound causes successive decreases in the slope of the binding curves

Limaprost-d3 Catalog No.:M26610-C The blocking Bcr-Abl kinase activityLimaprost d3 (17,20 dimethyl 2 PGE1 d3) is the deuterium labeled Limaprost. Limaprost (OP1206) is a PGE1 analogue and a potent and orally active vasodilator. Limaprost increases blood flow and inhibits platelet aggregation. Limaprost pain relief, has antianginal effects, and can be used for ischaemic symptoms research. Product information CAS Number: 1263190 37 9 Molecular Weight: 383. 54 Formula: C22H36O5 Chemical Name: (2E) 7 [(1R,2R,3R) 3 hydroxy 2